Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does AZATHIOPRINE Cause Therapy partial responder? 186 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 186 reports of Therapy partial responder have been filed in association with AZATHIOPRINE (AZATHIOPRINE). This represents 0.6% of all adverse event reports for AZATHIOPRINE.

186
Reports of Therapy partial responder with AZATHIOPRINE
0.6%
of all AZATHIOPRINE reports
10
Deaths
39
Hospitalizations

How Dangerous Is Therapy partial responder From AZATHIOPRINE?

Of the 186 reports, 10 (5.4%) resulted in death, 39 (21.0%) required hospitalization, and 8 (4.3%) were considered life-threatening.

Is Therapy partial responder Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for AZATHIOPRINE. However, 186 reports have been filed with the FAERS database.

What Other Side Effects Does AZATHIOPRINE Cause?

Drug ineffective (8,076) Off label use (5,358) Drug intolerance (3,392) Condition aggravated (2,832) Rheumatoid arthritis (2,746) Treatment failure (2,483) Arthralgia (2,427) Drug hypersensitivity (2,421) Nausea (2,178) Pneumonia (2,157)

What Other Drugs Cause Therapy partial responder?

CYCLOPHOSPHAMIDE (1,397) RITUXIMAB (1,219) DEXAMETHASONE (1,199) PREDNISONE (1,176) PEMBROLIZUMAB (1,125) CARBOPLATIN (1,096) DOXORUBICIN (834) METHOTREXATE (775) VINCRISTINE (707) ETOPOSIDE (670)

Which AZATHIOPRINE Alternatives Have Lower Therapy partial responder Risk?

AZATHIOPRINE vs AZD-1222 AZATHIOPRINE vs AZELAIC ACID AZATHIOPRINE vs AZELASTINE AZATHIOPRINE vs AZELASTINE\FLUTICASONE AZATHIOPRINE vs AZELNIDIPINE

Related Pages

AZATHIOPRINE Full Profile All Therapy partial responder Reports All Drugs Causing Therapy partial responder AZATHIOPRINE Demographics